An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma
Utilizing objective, continuous, and readily available variables, we developed and validated a new prediction model for early-stage cHL. Male sex, lower hemoglobin or albumin levels, and higher MTDs were associated with worse PFS. (Funded by the National Cancer Institute; grant number, NCI R01 CA 262265-04.).
Authors
- Susan K. Parsons (ORCID: https://orcid.org/0000-0003-0282-6490)
- Peter Johnson (ORCID: https://orcid.org/0000-0003-2306-4974)
- David Hodgson (ORCID: https://orcid.org/0000-0003-4687-4582)
- John Radford (ORCID: https://orcid.org/0000-0001-7898-2786)
- Andrea Gallamini (ORCID: https://orcid.org/0000-0002-2054-7412)
- Kerry J. Savage (ORCID: https://orcid.org/0000-0002-5835-9863)
- Andy Evans (ORCID: https://orcid.org/0000-0002-3320-0215)
- John Raemaekers
- Nicholas Counsell (ORCID: https://orcid.org/0000-0002-0688-9192)
- Eric Mou (ORCID: https://orcid.org/0000-0002-9865-4517)
- Matthew J. Maurer (ORCID: https://orcid.org/0000-0002-1867-0526)
- Ranjana H. Advani (ORCID: https://orcid.org/0000-0002-3219-2292)
- Annette E. Hay
- Martin Hutchings (ORCID: https://orcid.org/0000-0003-3873-1741)
- Cheryl Chang (ORCID: https://orcid.org/0000-0001-7810-0501)
- Richard T. Hoppe (ORCID: https://orcid.org/0000-0003-0125-0194)
- Marc André (ORCID: https://orcid.org/0000-0001-7101-810X)
- Sára Rossetti (ORCID: https://orcid.org/0000-0003-0508-5843)
- Angie Mae Rodday (ORCID: https://orcid.org/0000-0002-8671-3401)
- Jenica Upshaw (ORCID: https://orcid.org/0000-0001-5801-5481)
- Raphael Mwangi (ORCID: https://orcid.org/0000-0002-9004-9099)
- Stephen Opat (ORCID: https://orcid.org/0000-0002-0308-6458)
- Qingyan Xiang (ORCID: https://orcid.org/0000-0003-4717-3809)
- Cui Zhu
Institutions
- Rutgers, The State University of New Jersey (US)
- University of Iowa (US)
- Tufts Medical Center (US)
- Mayo Clinic (US)
- University of British Columbia (CA)
- University of Toronto (CA)
- Queen's University (CA)
- Cancer Research UK (GB)
- Copenhagen University Hospital (DK)
- Princess Margaret Cancer Centre (CA)
- Rigshospitalet (DK)
- University of Manchester (GB)
- London Cancer (GB)
- CHU Dinant Godinne UCL Namur (BE)
- Monash Health (AU)
- European Organisation for Research and Treatment of Cancer (BE)
- Centre Antoine Lacassagne (FR)
- NIHR Manchester Biomedical Research Centre (GB)
- University of Southampton (GB)
- University College London (GB)
- Monash University (AU)
- Stanford University (US)
Publication Details
- Journal
- NEJM Evidence
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1056/evidoa2500115
- Citations
- 2
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.94